Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...
Q4 2024 Earnings Call Transcript February 14, 2025 Moderna, Inc. misses on earnings expectations. Reported EPS is $-2.91 EPS, ...
Earnings: Discover insights into revenue shifts, cost reductions, 2027 product goals, RSV market strategies, and its broader ...
Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...
On today's call are Stéphane Bancel, Chief Executive Officer; Jamey Mock, Chief Financial Officer; and Stephen Hoge, President. Before we begin, please note that this conference call will include ...
On today's call are Stephane Bancel, Chief Executive Officer; Jamey Mock, Chief Financial Officer; and Stephen Hoge, President. Before we begin, please note that this conference call will include ...
On today's call are Stéphane Bancel, Chief Executive Officer; Jamey Mock, Chief Financial Officer; and Stephen Hoge, President. Before we begin, please note that this conference call will include ...
Stephen Hoge, President: Regarding Norovirus, GBS occurs in the background population, and we paused activities to prioritize patient safety. The FDA placed us on hold while reviewing our documents, ...
Stephen Hoge is one of three kickers vying for the starting job at Kansas University. Hoge is battling with fellow red-shirt freshman Jacob Branstetter and junior-college transfer Grady Fowler.
Mahery joins Moderna just over a year after the company bid farewell to its chief commercial officer, Arpa Garay, opting instead to split her sales and marketing work between Stephen Hoge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback